78 related articles for article (PubMed ID: 19524683)
1. Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression.
Stoppani E; Rossi S; Marchesini S; Preti A; Fanzani A
Cell Biol Int; 2009 Sep; 33(9):1020-5. PubMed ID: 19524683
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy.
Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
FEBS J; 2006 Aug; 273(16):3709-21. PubMed ID: 16869890
[TBL] [Abstract][Full Text] [Related]
3. The enzymatic activity of sialidase Neu2 is inversely regulated during in vitro myoblast hypertrophy and atrophy.
Fanzani A; Giuliani R; Colombo F; Rossi S; Stoppani E; Martinet W; Preti A; Marchesini S
Biochem Biophys Res Commun; 2008 May; 370(2):376-81. PubMed ID: 18384747
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells.
Fanzani A; Giuliani R; Colombo F; Zizioli D; Presta M; Preti A; Marchesini S
FEBS Lett; 2003 Jul; 547(1-3):183-8. PubMed ID: 12860410
[TBL] [Abstract][Full Text] [Related]
5. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
6. MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.
Faggi F; Codenotti S; Poliani PL; Cominelli M; Chiarelli N; Colombi M; Vezzoli M; Monti E; Bono F; Tulipano G; Fiorentini C; Zanola A; Lo HP; Parton RG; Keller C; Fanzani A
PLoS One; 2015; 10(6):e0130287. PubMed ID: 26086601
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MyoD-inducible lysosomal sialidase (neu1) inhibits myogenesis in C2C12 cells.
Champigny MJ; Perry R; Rudnicki M; Igdoura SA
Exp Cell Res; 2005 Nov; 311(1):157-66. PubMed ID: 16216242
[TBL] [Abstract][Full Text] [Related]
8. Cytosolic sialidase Neu2 upregulation during PC12 cells differentiation.
Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
FEBS Lett; 2004 May; 566(1-3):178-82. PubMed ID: 15147891
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
[TBL] [Abstract][Full Text] [Related]
10. 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.
Marchesi I; Sanna L; Fais M; Fiorentino FP; Giordano A; Bagella L
J Cell Physiol; 2018 Mar; 233(3):2360-2365. PubMed ID: 28722764
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
12. Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival.
Koseki K; Wada T; Hosono M; Hata K; Yamaguchi K; Nitta K; Miyagi T
Biochem Biophys Res Commun; 2012 Nov; 428(1):142-9. PubMed ID: 23068092
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells.
Ricaud S; Vernus B; Duclos M; Bernardi H; Ritvos O; Carnac G; Bonnieu A
Oncogene; 2003 Nov; 22(51):8221-32. PubMed ID: 14614446
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.
Tonin PN; Scrable H; Shimada H; Cavenee WK
Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137
[TBL] [Abstract][Full Text] [Related]
15. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
16. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
17. MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation.
Papini N; Anastasia L; Tringali C; Dileo L; Carubelli I; Sampaolesi M; Monti E; Tettamanti G; Venerando B
J Cell Biochem; 2012 Sep; 113(9):2967-78. PubMed ID: 22552967
[TBL] [Abstract][Full Text] [Related]
18. Expression of a novel human sialidase encoded by the NEU2 gene.
Monti E; Preti A; Nesti C; Ballabio A; Borsani G
Glycobiology; 1999 Dec; 9(12):1313-21. PubMed ID: 10561456
[TBL] [Abstract][Full Text] [Related]
19. The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells.
Berger F; Büchsler I; Munz B
Differentiation; 2012 Jun; 83(5):271-81. PubMed ID: 22469857
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor.
Thulasi R; Dias P; Houghton PJ; Houghton JA
Cell Growth Differ; 1996 Apr; 7(4):531-41. PubMed ID: 9052994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
